This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Memantine hydrochloride

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20221018

Version

4

Spl Product Data Elements

Memantine hydrochloride Memantine hydrochloride MEMANTINE HYDROCHLORIDE MEMANTINE AMMONIA ALCOHOL BUTYL ALCOHOL ETHYLCELLULOSE (7 MPA.S) GELATIN HYPROMELLOSES FERROSOFERRIC OXIDE ISOPROPYL ALCOHOL POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE SUCROSE TALC TRIETHYL CITRATE TITANIUM DIOXIDE WATER WHITE WHITE CAPSULE 546 Memantine hydrochloride Memantine hydrochloride MEMANTINE HYDROCHLORIDE MEMANTINE AMMONIA ALCOHOL BUTYL ALCOHOL ETHYLCELLULOSE (7 MPA.S) FERROSOFERRIC OXIDE FD&C BLUE NO. 1 FD&C RED NO. 3 FD&C YELLOW NO. 6 FERRIC OXIDE YELLOW GELATIN HYPROMELLOSES ISOPROPYL ALCOHOL POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE SUCROSE TALC TRIETHYL CITRATE TITANIUM DIOXIDE WATER LIGHT-BLUE GREEN CAPSULE 547 Memantine hydrochloride Memantine hydrochloride MEMANTINE HYDROCHLORIDE MEMANTINE AMMONIA ALCOHOL BUTYL ALCOHOL ETHYLCELLULOSE (7 MPA.S) FERROSOFERRIC OXIDE FD&C BLUE NO. 2 FERRIC OXIDE YELLOW GELATIN HYPROMELLOSES ISOPROPYL ALCOHOL POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE SUCROSE TALC TRIETHYL CITRATE TITANIUM DIOXIDE WATER WHITE GREEN CAPSULE 548 Memantine hydrochloride Memantine hydrochloride MEMANTINE HYDROCHLORIDE MEMANTINE AMMONIA ALCOHOL BUTYL ALCOHOL ETHYLCELLULOSE (7 MPA.S) FERROSOFERRIC OXIDE FD&C BLUE NO. 2 FERRIC OXIDE YELLOW GELATIN HYPROMELLOSES ISOPROPYL ALCOHOL POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE SUCROSE TALC TRIETHYL CITRATE TITANIUM DIOXIDE WATER LIGHT-GREEN LIGHT-GREEN CAPSULE 549

Application Number

ANDA203293

Brand Name

Memantine hydrochloride

Generic Name

Memantine hydrochloride

Product Ndc

70771-1322

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Memantine Hydrochloride Extended-release Capsules, 7 mg NDC 70771-1321-3 30 Counts Memantine Hydrochloride Extended-release Capsules, 14 mg 70771-1322-3 30 Counts Memantine Hydrochloride Extended-release Capsules, 21 mg NDC 70771-1323-3 30 Counts Memantine Hydrochloride Extended-release Capsules, 28 mg NDC 70771-1324-3 30 Counts Memantine Hydrochloride Extended-Release Capsules, 7 mg Memantine Hydrochloride Extended-Release Capsules, 14 mg Memantine Hydrochloride Extended-release Capsules, 21 mg Memantine Hydrochloride Extended-release Capsules, 28 mg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.